Athersys
ATHX
$0.01350
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
P/S ratio for Athersys (ATHX)
P/S ratio as of April 2024 (TTM): 10.4
According to Athersys's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.415. At the end of 2023 the company had a P/S ratio of 144.
P/S ratio history for Athersys from 2008 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 144 | 5214.19% |
| 2022 | 2.72 | -92.95% |
| 2021 | 38.5 | -84.4% |
| 2020 | 247 | 592.84% |
| 2019 | 35.6 | 306.98% |
| 2018 | 8.75 | -88.4% |
| 2017 | 75.5 | 833.48% |
| 2016 | 8.08 | -3.46% |
| 2015 | 8.37 | -98.05% |
| 2014 | 429 | 83.42% |
| 2013 | 234 | 2528.81% |
| 2012 | 8.90 | 126.49% |
| 2011 | 3.93 | -24.85% |
| 2010 | 5.23 | -85.55% |
| 2009 | 36.2 | 1219.72% |
| 2008 | 2.74 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | -63.65% | 🇺🇸 USA |
 Pfizer PFE | 2.46 | -76.40% | 🇺🇸 USA |
 Amgen AMGN | 5.14 | -50.68% | 🇺🇸 USA |
 Sanofi SNY | 2.44 | -76.58% | 🇫🇷 France |
 Merck MRK | 5.53 | -46.92% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.02 | -80.59% | 🇺🇸 USA |
 Moderna
MRNA | 6.12 | -41.24% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |